Physician profile
Claudio Sandoval
NPI 1295722999
$53,597.58
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2021: $263 · 2022: $95.16 · 2023: $41.46 · 2024: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $156 · Food and Beverage: $65.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $156.46 |
| Food and Beverage | $65.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $47,094.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $5,783.18 | 2019 | |
| Octapharma USA, INC. | $444.16 | 2021-2024 | Wilate - Von Willebrand Factor/Coagulation Factor Viii Complex (Human), Nuwiq |
| Genentech USA, INC. | $143.21 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $41.46 | 2023 | |
| Genzyme Corporation | $39.57 | 2019 | |
| Amgen INC. | $28.90 | 2019 | |
| Sobi, INC | $22.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudio Sandoval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.